mRNA Innovations

Technology Advances Needed to Drive Future mRNA Growth

Hagen Richter, Ph.D.

mRNA Manufacturing

Navigating mRNA Manufacturing with Flexibility and Innovation

Michael van der Horst, Ph.D.

New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

Jessica Madigan; Normand Blais

BIOVECTRA

Risk Management in mRNA Manufacture

Managing Risk in Cutting-Edge mRNA Therapeutics

Jessica Madigan; Normand Blais

BIOVECTRA

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

Eunseo (Ency) Lee, Ph.D; Jungkeun (Henry) Oh; Hanel Hwang

Samsung Biologics

mRNA Manufacturing

Investing in the Future of mRNA Manufacturing

Esther Yoo, Ph.D.

Samsung Biologics

Quality in mRNA Manufacturing

Quality in Equals Quality Out in mRNA Manufacturing

Judith McCorry

Vernal Biosciences

mRNA Manufacture

Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers

Tonia Becker

Nice Insight

mRNA Manufacturing

Overcoming Bottlenecks in mRNA Manufacturing

Pierre Catignol; Huisub Lim

Samsung Biologics

mRNA

Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

mRNA Manufacturing

Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth

Vernal Biosciences

Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

mRNA

Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects

Scott Doncaster; Marc Sauer, Ph.D.

BIOVECTRA

Facility Acquisition

MilliporeSigma Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-Up

MilliporeSigma

CDMO Acquisition

Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand its Biologics Offering in the U.S.

Recipharm

mRNA Vaccine Manufacturing

Presenting an Integrated Solution for mRNA Vaccine Manufacturing

Mark Bamforth; Dave Stevens

Arranta Bio

mRNA Manufacturing

Serving an Accelerated Market with mRNA Production

Mark Bamforth

Arranta Bio

Investing in mRNA Production

Michael Wourms

Arranta Bio

mRNA Manufacturing

Limiting Risk In mRNA Development and Production

Doug Kennedy

Arranta Bio